Neurocrine Biosciences (NBIX) Shares Issued (2010 - 2019)

Neurocrine Biosciences' Shares Issued history runs 10 years deep, the most recent figure standing at $4.0 million for Q4 2019.

• Quarterly Shares Issued fell 30.39% year-over-year to $4.0 million in Q4 2019, while the trailing twelve-month figure through Dec 2019 was $4.0 million (down 30.39% YoY) and the FY2019 annual result came in at $4.0 million, down 30.39% from the prior year.
• Shares Issued was $4.0 million for Q4 2019 at Neurocrine Biosciences, down from $5.7 million in the prior quarter.
• Across five years, Shares Issued topped out at $6.4 million in Q4 2017 and bottomed at $4.0 million in Q4 2019.
• A 5-year average of $5.5 million and a median of $5.7 million in 2018 frame the typical range for Shares Issued.
• Annual changes were most pronounced in 2016 — Shares Issued climbed 10.99% — and 2019, when it tumbled 30.39%.
• Neurocrine Biosciences' Shares Issued stood at $5.5 million in 2015, then rose by 10.99% to $6.1 million in 2016, then climbed by 3.99% to $6.4 million in 2017, then declined by 9.6% to $5.7 million in 2018, then plunged by 30.39% to $4.0 million in 2019.
• Business Quant data shows NBIX's Shares Issued at $4.0 million in Q4 2019, $5.7 million in Q4 2018, and $6.4 million in Q4 2017.